vs

Side-by-side financial comparison of NetEase, Inc. (NTES) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $4.0B, roughly 1.4× NetEase, Inc.). NetEase, Inc. runs the higher net margin — 31.0% vs 11.7%, a 19.4% gap on every dollar of revenue. NetEase, Inc. produced more free cash flow last quarter ($1.8B vs $367.0M). Over the past eight quarters, NetEase, Inc.'s revenue compounded faster (9.7% CAGR vs 1.5%).

NetEase, Inc. is a Chinese developer and publisher of online PC and mobile games, advertising services, email services, and e-commerce platforms. It is one of the largest Internet and video game companies in the world and was founded by Ding Lei in June 1997.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

NTES vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.4× larger
THC
$5.5B
$4.0B
NTES
Higher net margin
NTES
NTES
19.4% more per $
NTES
31.0%
11.7%
THC
More free cash flow
NTES
NTES
$1.4B more FCF
NTES
$1.8B
$367.0M
THC
Faster 2-yr revenue CAGR
NTES
NTES
Annualised
NTES
9.7%
1.5%
THC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
NTES
NTES
THC
THC
Revenue
$4.0B
$5.5B
Net Profit
$1.2B
$644.0M
Gross Margin
64.1%
Operating Margin
28.3%
15.4%
Net Margin
31.0%
11.7%
Revenue YoY
9.0%
Net Profit YoY
12.6%
EPS (diluted)
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTES
NTES
THC
THC
Q4 25
$5.5B
Q3 25
$4.0B
$5.3B
Q2 25
$3.9B
$5.3B
Q1 25
$4.0B
$5.2B
Q4 24
$5.1B
Q3 24
$3.7B
$5.1B
Q2 24
$3.5B
$5.1B
Q1 24
$3.7B
$5.4B
Net Profit
NTES
NTES
THC
THC
Q4 25
$644.0M
Q3 25
$1.2B
$579.0M
Q2 25
$1.3B
$522.0M
Q1 25
$1.5B
$622.0M
Q4 24
$572.0M
Q3 24
$955.7M
$681.0M
Q2 24
$939.6M
$477.0M
Q1 24
$1.1B
$2.3B
Gross Margin
NTES
NTES
THC
THC
Q4 25
Q3 25
64.1%
Q2 25
64.7%
Q1 25
64.1%
Q4 24
Q3 24
62.9%
Q2 24
62.9%
Q1 24
63.4%
Operating Margin
NTES
NTES
THC
THC
Q4 25
15.4%
Q3 25
28.3%
16.8%
Q2 25
32.5%
15.6%
Q1 25
36.2%
18.1%
Q4 24
16.2%
Q3 24
27.3%
21.3%
Q2 24
27.4%
14.9%
Q1 24
28.4%
61.2%
Net Margin
NTES
NTES
THC
THC
Q4 25
11.7%
Q3 25
31.0%
10.9%
Q2 25
32.6%
9.9%
Q1 25
36.6%
11.9%
Q4 24
11.3%
Q3 24
25.6%
13.3%
Q2 24
26.8%
9.3%
Q1 24
29.1%
43.5%
EPS (diluted)
NTES
NTES
THC
THC
Q4 25
$4.22
Q3 25
$3.86
Q2 25
$3.14
Q1 25
$4.27
Q4 24
$3.79
Q3 24
$4.89
Q2 24
$2.64
Q1 24
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTES
NTES
THC
THC
Cash + ST InvestmentsLiquidity on hand
$31.3B
$2.9B
Total DebtLower is stronger
$13.1B
Stockholders' EquityBook value
$160.8B
$4.2B
Total Assets
$214.5B
$29.7B
Debt / EquityLower = less leverage
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTES
NTES
THC
THC
Q4 25
$2.9B
Q3 25
$31.3B
$3.0B
Q2 25
$54.4B
$2.6B
Q1 25
$41.7B
$3.0B
Q4 24
$3.0B
Q3 24
$20.2B
$4.1B
Q2 24
$19.0B
$2.9B
Q1 24
$43.0B
$2.5B
Total Debt
NTES
NTES
THC
THC
Q4 25
$13.1B
Q3 25
$13.1B
Q2 25
$13.1B
Q1 25
$13.1B
Q4 24
$13.1B
Q3 24
$12.8B
Q2 24
$12.8B
Q1 24
$12.8B
Stockholders' Equity
NTES
NTES
THC
THC
Q4 25
$4.2B
Q3 25
$160.8B
$4.0B
Q2 25
$154.0B
$3.7B
Q1 25
$147.8B
$4.2B
Q4 24
$4.2B
Q3 24
$135.6B
$3.8B
Q2 24
$134.2B
$3.5B
Q1 24
$130.5B
$3.5B
Total Assets
NTES
NTES
THC
THC
Q4 25
$29.7B
Q3 25
$214.5B
$29.4B
Q2 25
$208.5B
$28.7B
Q1 25
$200.9B
$29.2B
Q4 24
$28.9B
Q3 24
$184.9B
$29.4B
Q2 24
$183.3B
$29.3B
Q1 24
$195.1B
$28.9B
Debt / Equity
NTES
NTES
THC
THC
Q4 25
3.10×
Q3 25
3.26×
Q2 25
3.49×
Q1 25
3.13×
Q4 24
3.14×
Q3 24
3.33×
Q2 24
3.67×
Q1 24
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTES
NTES
THC
THC
Operating Cash FlowLast quarter
$1.8B
$731.0M
Free Cash FlowOCF − Capex
$1.8B
$367.0M
FCF MarginFCF / Revenue
44.7%
6.6%
Capex IntensityCapex / Revenue
1.0%
6.6%
Cash ConversionOCF / Net Profit
1.47×
1.14×
TTM Free Cash FlowTrailing 4 quarters
$6.3B
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTES
NTES
THC
THC
Q4 25
$731.0M
Q3 25
$1.8B
$1.1B
Q2 25
$1.5B
$936.0M
Q1 25
$1.7B
$815.0M
Q4 24
$-331.0M
Q3 24
$1.5B
$1.0B
Q2 24
$898.8M
$747.0M
Q1 24
$1.3B
$586.0M
Free Cash Flow
NTES
NTES
THC
THC
Q4 25
$367.0M
Q3 25
$1.8B
$778.0M
Q2 25
$1.5B
$743.0M
Q1 25
$1.6B
$642.0M
Q4 24
$-661.0M
Q3 24
$1.5B
$829.0M
Q2 24
$875.6M
$602.0M
Q1 24
$1.3B
$346.0M
FCF Margin
NTES
NTES
THC
THC
Q4 25
6.6%
Q3 25
44.7%
14.7%
Q2 25
38.3%
14.1%
Q1 25
40.4%
12.3%
Q4 24
-13.0%
Q3 24
38.9%
16.2%
Q2 24
25.0%
11.8%
Q1 24
34.0%
6.4%
Capex Intensity
NTES
NTES
THC
THC
Q4 25
6.6%
Q3 25
1.0%
5.3%
Q2 25
0.7%
3.7%
Q1 25
1.6%
3.3%
Q4 24
6.5%
Q3 24
1.4%
4.2%
Q2 24
0.7%
2.8%
Q1 24
1.5%
4.5%
Cash Conversion
NTES
NTES
THC
THC
Q4 25
1.14×
Q3 25
1.47×
1.83×
Q2 25
1.20×
1.79×
Q1 25
1.15×
1.31×
Q4 24
-0.58×
Q3 24
1.58×
1.53×
Q2 24
0.96×
1.57×
Q1 24
1.22×
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NTES
NTES

Games and related value-added services$3.3B82%
NetEase Cloud Music$275.9M7%
Youdao$228.8M6%
Innovative businesses and others$202.1M5%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons